MHRA

GSK

Pharma

GSK kicks off Blenrep's market return with first combo nod in UK

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022.

Angus Liu Apr 17, 2025 2:29pm

two red lights

NICE again rejects Alzheimer's drugs from Lilly and Biogen/Eisai

Mar 6, 2025 10:47am

traffic lights

England's NICE not sold on Lilly's Kisunla despite UK approval

Oct 23, 2024 11:00am

Eli Lillys Mounjaro

NHS England proposes phased rollout for Lilly's obesity med

Oct 3, 2024 3:22pm

LinkedIn post lands Vertex in hot water with MHRA

Aug 22, 2024 11:00am

Leqembi official photo

Eisai, Biogen's Leqembi nabs UK nod but not reimbursement

Aug 22, 2024 9:23am